DUBLIN--(BUSINESS WIRE)--The "India Veterinary Healthcare Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
Zoonotic diseases are naturally transmitted from animals to humans, due to the consumption of contaminated food and water, and exposure to the pathogen during preparation, processing, or by direct contact with infected animals or humans. Zoonotic diseases are caused by microorganisms, like viruses, bacteria, parasites, and fungi. Microbes can cause different types of diseases in humans and animals, ranging from mild to serious infections, and can even lead to death. As per the International Livestock Research Institute (ILRI) study, 27% of the livestock in India showed signs of being infected with bacterial food-borne diseases, which are sources of food contamination. Among the developing countries, India has the highest zoonotic disease burden, with widespread illness and death. Hence, owing to these factors, the market is expected to grow in the forecast period.
Key Market Trends
Vaccines Segment is Expected to Show Better Growth in the Forecast Years
Based on Therapeutics, the market is segmented into Vaccines, Parasiticides, Anti-Infectives, Medical Feed Additives and Other Therapeutics. The growth of vaccine segment is mainly attributed to attributed to the increasing initiatives by animal welfare associations, and advanced technologies leading to innovation in animal healthcare. In several cases of food-producing animals, the industry and governments work closely to develop vaccines against major outbreak of diseases in animals, such as the Aujeszky's disease, bluetongue, bovine tuberculosis, and foot and mouth disease are some of the most common diseases among animals. Hence, owing to risk of emerging zoonotic diseases, the vaccines segment is expected to witness rapid growth over the forecast period.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format.
- 3 months of analyst support.
Key Topics Covered:
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Advanced Technology Leading to Innovations in Animal Healthcare
4.2.2 Risk of Emerging Zoonosis
4.3 Market Restraints
4.3.1 Use of Counterfeit Medicines
4.3.2 Increasing Costs of Animal Testing and Veterinary Services
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 By Therapeutics
188.8.131.52 Anti Infectives
184.108.40.206 Medical Feed Additives
220.127.116.11 Other Therapeutics
5.1.2 By Diagnostics
18.104.22.168 Immunodiagnostic Tests
22.214.171.124 Molecular Diagnostics
126.96.36.199 Diagnostic Imaging
188.8.131.52 Clinical Chemistry
184.108.40.206 Other Diagnostics
5.2 By Animal Type
5.2.1 Dogs and Cats
5.2.6 Other Animals
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Boehringer Ingelheim GmbH
6.1.2 Elanco Animal Health
6.1.3 IDEXX Laboratories, Inc.
6.1.4 Merck & Co. Inc.
6.1.7 Zoetis Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/3b9lcn